Cohen & Co Inc. (COHN) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US19249M1027
Cohen & Co Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 275.56 m USD |
| Operating income | 59.41 m USD |
| EBIT | 49.01 m USD |
| Net income | 14.43 m USD |
| Diluted EPS – continuing operations | 4.35 USD |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cohen & Co Inc.
Cohen & Company Inc. is a publicly owned investment manager. The firm primarily provides its services to individuals and institutions. It manages separate client-focused fixed income portfolios. Institutional Financial Markets, Inc. also manages funds and collateralized debt obligations for its clients. It invests in the fixed income and alternative investment markets across the globe. The firm's fixed income investments include U.S. trust preferred securities, European hybrid capital securities, Asian commercial real estate debt, mortgage backed securities, and asset backed securities. The firm was formerly known as Institutional Financial Markets, Inc. Cohen & Company Inc. was founded in 1999 and is based in Philadelphia, Pennsylvania with additional offices in New York City; Boca Raton, Florida; Chicago, Illinois; Bethesda, Maryland; Boston, Massachusetts; Paris, France; and London, United Kingdom.
More stocks
- Vanguard Green Investment Ltd (VGES)
- HyOrc Corp (HYOR)
- Future FinTech Group Inc. (FTFT)
- PIXELWORKS, INC (PXLW)
- AUTOSCOPE TECHNOLOGIES CORP (AATC)
- Viscount Mining Corp. (VML.V)
- LeonaBio, Inc. (LONA)
- RESERVE PETROLEUM CO (RSRV)
- TuSimple Holdings Inc. (TSPH)
- DMS Propertindo Tbk PT (KOTA.JK)
- Inmune Bio, Inc. (INMB)
- SCYNEXIS INC (SCYX)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.